Expression Table for this CRE
| SRX14972986 | Primary keratinocytes from P0 back skin, genotype: R26-Sox2-IRES-eGFP fl/+ | 469.3 |
| SRX14972985 | Primary keratinocytes from P0 back skin, genotype: R26-Sox2-IRES-eGFP fl/+ | 437.5 |
| SRX3635523 | skin of post natal day 28 control mouse C57BL/6J background | 372.4 |
| SRX4504811 | mouse NET-CAGE brain, biol_rep1 | 356.6 |
| SRX3635525 | skin of post natal day 28 control mouse C57BL/6J background | 346.7 |
| SRX14972989 | Primary keratinocytes from P0 back skin, genotype: HrasG12V; Tgfbr2 fl/fl KO | 346.0 |
| SRX3635522 | skin of post natal day 28 control mouse C57BL/6J background | 336.0 |
| SRX4504808 | mouse CAGE kidney samples, biol_rep2 | 321.6 |
| SRX4504805 | mouse CAGE kidney samples, biol_rep1 | 316.0 |
| SRX690757 | Mdr2-KO liver female etiology/histology:40% AD, 0% HCC | 308.8 |
| SRX14972990 | Primary keratinocytes from P0 back skin, genotype: HrasG12V; Tgfbr2 fl/fl KO | 303.0 |
| SRX4504802 | mouse CAGE brain, biol_rep1 | 302.8 |
| SRX690755 | Mdr2-KO liver male etiology/histology:Inflammation | 302.1 |
| SRX690753 | WT liver male etiology/histology:WT | 300.7 |
| CNhs10505 | spinal cord, adult | 300.2 |
| CNhs10581 | thymus, embryo E17 | 298.0 |
| SRX690754 | Mdr2-KO liver male etiology/histology:Inflammation | 293.9 |
| SRX690751 | WT liver male etiology/histology:WT | 290.6 |
| SRX690756 | Mdr2-KO liver male etiology/histology:Inflammation | 288.6 |
| SRX690752 | WT liver male etiology/histology:WT | 286.0 |
| SRX690749 | WT liver male etiology/histology:WT | 285.7 |
| SRX690769 | Mdr2-KO liver male etiology/histology:70% AD, 30% HCC | 285.1 |
| CNhs10506 | intestinal mucosa, adult | 282.3 |
| CNhs10504 | testis, adult | 281.4 |
| SRX690750 | WT liver male etiology/histology:WT | 278.3 |
| SRX690766 | Mdr2-KO liver female etiology/histology:30% AD, 40% HCC | 277.6 |
| SRX690784 | Mdr2-KO liver male etiology/histology:0% AD, 60% HCC | 274.5 |
| SRX690768 | Mdr2-KO liver male etiology/histology:80% AD, 20% HCC | 273.0 |
| SRX690767 | Mdr2-KO liver male etiology/histology:80% AD, 10% HCC | 272.7 |
| SRX690760 | Mdr2-KO liver male etiology/histology:60% AD, 0% HCC | 271.5 |
| SRX690783 | Mdr2-KO liver male etiology/histology:10% AD, 60% HCC | 269.3 |
| SRX690748 | WT liver male etiology/histology:WT | 269.3 |
| SRX690765 | Mdr2-KO liver male etiology/histology:50% AD, 20% HCC | 267.5 |
| SRX690761 | Mdr2-KO liver male etiology/histology:70% AD, 20% HCC | 266.1 |
| SRX690758 | Mdr2-KO liver male etiology/histology:30% AD, 0% HCC | 265.3 |
| SRX4504814 | mouse NET-CAGE kidney samples, biol_rep1 | 265.0 |
| SRX4504817 | mouse NET-CAGE kidney samples, biol_rep2 | 262.8 |
| CNhs12770 | J2E erythroblastic leukemia response to erythropoietin, 00hr00min, biol_rep3 | 260.3 |
| SRX690762 | Mdr2-KO liver male etiology/histology:70% AD, 10% HCC | 259.7 |
| SRX690763 | Mdr2-KO liver female etiology/histology:10% AD, 20% HCC | 257.7 |
| SRX690771 | Mdr2-KO liver female etiology/histology:80% AD, 10% HCC | 256.5 |
| CNhs10503 | stomach, adult | 255.8 |
| SRX690764 | Mdr2-KO liver male etiology/histology:60% AD, 10% HCC | 255.1 |
| SRX690759 | Mdr2-KO liver male etiology/histology:20% AD, 0% HCC | 254.7 |
| SRX690770 | Mdr2-KO liver male etiology/histology:70% AD, 10% HCC | 254.5 |
| SRX690772 | Mdr2-KO liver female etiology/histology:80% AD, 10% HCC | 253.2 |
| SRX3635524 | skin of post natal day 28 control mouse C57BL/6J background | 251.5 |
| CNhs10507 | ovary, adult | 250.9 |
| SRX7078888 | IPMN cell lines derived from mouse models of pancreatic cancer: Ptf1a-Cre; KrasG12D; Brg1f/f PDA | 249.2 |
| SRX690773 | Mdr2-KO liver male etiology/histology:70% AD, 20% HCC | 248.7 |